X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs PFIZER - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. PFIZER WOCKHARDT LTD./
PFIZER
 
P/E (TTM) x -15.9 31.4 - View Chart
P/BV x 2.6 5.0 52.1% View Chart
Dividend Yield % 1.3 0.6 195.2%  

Financials

 WOCKHARDT LTD.   PFIZER
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
PFIZER
Mar-16
WOCKHARDT LTD./
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,1292,724 41.4%   
Low Rs6271,611 38.9%   
Sales per share (Unadj.) Rs363.1440.9 82.4%  
Earnings per share (Unadj.) Rs-20.448.7 -42.0%  
Cash flow per share (Unadj.) Rs-7.075.8 -9.2%  
Dividends per share (Unadj.) Rs10.0015.00 66.7%  
Dividend yield (eoy) %1.10.7 164.6%  
Book value per share (Unadj.) Rs301.8462.9 65.2%  
Shares outstanding (eoy) m110.5545.75 241.6%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x2.44.9 49.2%   
Avg P/E ratio x-42.944.5 -96.5%  
P/CF ratio (eoy) x-125.928.6 -440.0%  
Price / Book Value ratio x2.94.7 62.1%  
Dividend payout %-48.930.8 -158.8%   
Avg Mkt Cap Rs m97,06399,163 97.9%   
No. of employees `0006.82.9 234.3%   
Total wages/salary Rs m9,6652,758 350.5%   
Avg. sales/employee Rs Th5,931.86,981.7 85.0%   
Avg. wages/employee Rs Th1,428.1954.5 149.6%   
Avg. net profit/employee Rs Th-334.0771.1 -43.3%   
INCOME DATA
Net Sales Rs m40,14620,170 199.0%  
Other income Rs m1,143857 133.3%   
Total revenues Rs m41,28921,028 196.4%   
Gross profit Rs m1284,310 3.0%  
Depreciation Rs m1,4891,239 120.2%   
Interest Rs m2,2535 43,321.2%   
Profit before tax Rs m-2,4723,923 -63.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m-2111,794 -11.8%   
Profit after tax Rs m-2,2602,228 -101.5%  
Gross profit margin %0.321.4 1.5%  
Effective tax rate %8.545.7 18.7%   
Net profit margin %-5.611.0 -51.0%  
BALANCE SHEET DATA
Current assets Rs m46,16016,299 283.2%   
Current liabilities Rs m19,2587,594 253.6%   
Net working cap to sales %67.043.2 155.3%  
Current ratio x2.42.1 111.7%  
Inventory Days Days10165 154.3%  
Debtors Days Days9426 365.2%  
Net fixed assets Rs m40,1658,622 465.8%   
Share capital Rs m553458 120.8%   
"Free" reserves Rs m32,81420,722 158.4%   
Net worth Rs m33,36721,180 157.5%   
Long term debt Rs m31,90325 127,610.8%   
Total assets Rs m89,68729,137 307.8%  
Interest coverage x-0.1755.5 -0.0%   
Debt to equity ratio x1.00 81,001.5%  
Sales to assets ratio x0.40.7 64.7%   
Return on assets %07.7 -0.1%  
Return on equity %-6.810.5 -64.4%  
Return on capital %-0.319.0 -1.8%  
Exports to sales %00.1 0.0%   
Imports to sales %017.5 0.0%   
Exports (fob) Rs mNA12 0.0%   
Imports (cif) Rs mNA3,526 0.0%   
Fx inflow Rs m9,12152 17,658.9%   
Fx outflow Rs m2,133140 1,523.9%   
Net fx Rs m6,988-88 -7,910.8%   
CASH FLOW
From Operations Rs m-2,6953,436 -78.4%  
From Investments Rs m-6,863-6,991 98.2%  
From Financial Activity Rs m12,545-619 -2,027.3%  
Net Cashflow Rs m3,010-4,174 -72.1%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 2.3 7.5 30.7%  
FIIs % 7.7 4.9 157.1%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 23.7 65.0%  
Shareholders   67,757 85,207 79.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   DR. DATSONS LABS  STRIDES SHASUN LTD  J.B.CHEMICALS  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare WOCKHARDT LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Rebound After Sharp Weekly Drop(RoundUp)

Global financial markets rallied this week and brushed aside a rise in global borrowing costs while the dollar hit its lowest level since 2014.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

As the Market Corrects... It's Time to Buy More(Smart Contrarian)

Feb 5, 2018

The recent sell off in the stock market offers buying opportunity in some quality small caps.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Feb 16, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - PIRAMAL ENTERPRISES COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS